NASDAQ: AVEO       Aveo Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
0.591   -0.013 (2.15%)  0.58 - 0.62  1,043,300


Avg Volume (4 weeks):1,186,066
4 Weeks Range:0.58 - 0.70
4 Weeks Price Volatility (%):
52 Weeks Range:0.469 - 1.85
52 Weeks Price Volatility (%):
Average Price Target: 8.00
Price Target Upside/Downside: +7.409


No recent Headlines for this stock.

Business Background

AVEO Pharmaceuticals Inc operates as a biopharmaceutical company, which is engaged in the advancement of therapeutics for oncology and other areas of unmet medical need. The company views its operations and manages its business in the US. The firm offers products such as Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. Tivozanib is designed to optimize vascular endothelial growth factor blockade while minimizing off-target toxicities, Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity, AV-380, a humanized inhibitory monoclonal antibody for the treatment or prevention of cachexia; and the AV-353 platform for the potential treatment of pulmonary arterial hypertension.

  felgueiras likes this.


1843  6298  540  225 

Top 10 Active Counters
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers